| Autor: |
Zawada WM; Department of Medicine, University of Colorado School of Medicine, Denver 80262, USA., Cibelli JB, Choi PK, Clarkson ED, Golueke PJ, Witta SE, Bell KP, Kane J, Ponce de Leon FA, Jerry DJ, Robl JM, Freed CR, Stice SL |
| Jazyk: |
angličtina |
| Zdroj: |
Nature medicine [Nat Med] 1998 May; Vol. 4 (5), pp. 569-74. |
| DOI: |
10.1038/nm0598-569 |
| Abstrakt: |
Parkinson's disease symptoms can be improved by transplanting fetal dopamine cells into the putamen of parkinsonian patients. Because the supply of human donor tissue is limited and variable, an alternative and genetically modifiable non-human source of tissue would be valuable. We have generated cloned transgenic bovine embryos, 42% of which developed beyond 40 days. Dopamine cells collected from the ventral mesencephalon of the cloned fetuses 42 to 50 days post-conception survived transplantation into immunosuppressed parkinsonian rats and cells from cloned and wild-type embryos improved motor performance. Somatic cell cloning can efficiently produce transgenic animal tissue for treating parkinsonism. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
